Background To assess potentially elevated cardiovascular risk related to new antihyperglycemic
drugs in patients with type 2 diabetes, regulatory agencies require a comprehensive …

Improvements in sensor accuracy, greater convenience and ease of use, and expanding
reimbursement have led to growing adoption of continuous glucose monitoring (CGM). …

Objective: To review the evidence about the impact of hypoglycemia on patients with diabetes
that has become available since the past reviews of this subject by the American Diabetes …

Measurement of glycated hemoglobin (HbA 1c ) has been the traditional method for assessing
glycemic control. However, it does not reflect intra- and interday glycemic excursions that …

Background Severe hypoglycemia may increase the risk of a poor outcome in patients with
type 2 diabetes assigned to an intensive glucose-lowering intervention. We analyzed data …

Objective: The aim is to provide guidelines for the evaluation and management of adults
with hypoglycemic disorders, including those with diabetes mellitus. Evidence: Using the …

Background The impact of COVID-19 on physical and mental health and employment after
hospitalisation with acute disease is not well understood. The aim of this study was to …

Background In the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified
Release Controlled Evaluation (ADVANCE) factorial trial, the combination of perindopril …

The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …

To test the hypothesis that hypoglycemia itself causes reduced neuroendocrine and
symptomatic responses to subsequent hypoglycemia, we measured those responses during …